Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geodrill Announces Record First Quarter 2025 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clever Leaves Holdings Equity Warrant CLVRW

Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and... see more

Recent & Breaking News (GREY:CLVRW)

Clever Leaves Strengthens Its Presence in the U.S. Through Partnership With Biom Therapeutics

GlobeNewswire April 20, 2022

Clever Leaves to Present at Upcoming April Investor Conferences

GlobeNewswire April 5, 2022

Clever Leaves Ready to Export Dried Flower From Colombia

GlobeNewswire April 4, 2022

Clever Leaves Reports Fourth Quarter and Full Year 2021 Results

GlobeNewswire March 24, 2022

InterCure and Clever Leaves Announce International Strategic Partnership

GlobeNewswire March 22, 2022

Clever Leaves Appoints William Muecke to Board of Directors

GlobeNewswire March 17, 2022

Clever Leaves to Hold Fourth Quarter and Full Year 2021 Conference Call on March 24, 2022 at 5:00 p.m. ET

GlobeNewswire March 10, 2022

Clever Leaves to Present at the 34th Annual ROTH Conference

GlobeNewswire March 8, 2022

Clever Leaves Partners With FoliuMed to Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany

GlobeNewswire March 2, 2022

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia

GlobeNewswire February 28, 2022

Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa Verde

GlobeNewswire February 22, 2022

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership

GlobeNewswire February 17, 2022

Clever Leaves Expands Relationship With Cannatrek in Australia With a Two-Year $3.6M Sales Agreement

GlobeNewswire February 14, 2022

Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook

GlobeNewswire February 9, 2022

Clever Leaves Announces Leadership Transition Plan

GlobeNewswire February 9, 2022

Clever Leaves Appoints George Schultze to Board of Directors

GlobeNewswire February 2, 2022

Clever Leaves Enters US Consumer CBD Market

GlobeNewswire January 26, 2022

Clever Leaves to Present at the 2022 ICR Conference

GlobeNewswire January 7, 2022

Clever Leaves' Licensed Expansion Doubles Portuguese Production Capacity and Diversifies Export Potential

GlobeNewswire December 21, 2021

Clever Leaves to Present at Upcoming November and December Investor Conferences

GlobeNewswire November 23, 2021